INS and neoplasm: In patients treated with metformin there was an increase in the expression of tumour pAMPK, reduction in pAkt and suppression of insulin responses, as well as a significant decrease in Ki67 and cleaved caspase-3, suggesting that metformin may exert a cytostatic anti-tumour effect [135].